Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updated 2026 Comprehensive Evidence-Based Guidelines for Facet Joint Interventions in the Management of Chronic Spinal Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.

Pain physician·2026
Same author

Management and Outcomes of Firework-Related Hand Blast Injuries: A Case Series on Surgical Decision-Making, Functional Preservation, and Psychosocial Recovery.

Cureus·2026
Same author

Little Fingers, Big Problems: Understanding Pediatric Trigger Fingers.

Cureus·2026
Same author

Evaluating the Necessity of Deltoid Ligament Repair in Ankle Fractures: A Systematic Review and Meta-Analysis.

Cureus·2026
Same author

Human Papillomavirus (HPV)-Associated Primary Squamous Cell Carcinoma of the Rectosigmoid Colon: A Case Report and Literature Review of a Rare Malignancy.

Cureus·2026
Same author

Simultaneous Quadriceps Tendon Rupture, Contralateral Patellar Tendon Rupture, and Lateral Meniscus Tear Following a Single Fall: A Case Report.

Cureus·2026

Related Experiment Video

Updated: Aug 5, 2025

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.4K

Therapeutic advances in leiomyosarcoma.

Kristine Lacuna1, Sminu Bose1, Matthew Ingham1

  • 1Division of Hematology and Medical Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, United States.

Frontiers in Oncology
|March 27, 2023
PubMed
Summary
This summary is machine-generated.

Advanced leiomyosarcoma treatment remains challenging. Novel therapies targeting DNA repair and metabolism show promise, alongside new chemotherapy combinations, improving outcomes for this aggressive cancer.

Keywords:
clinical trialsleiomyosarcoma (LMS)sarcomasoft tissue sarcoma (STS)therapeutics

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.7K
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.5K

Related Experiment Videos

Last Updated: Aug 5, 2025

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.4K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.7K
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.5K

Area of Science:

  • Oncology
  • Cancer Biology
  • Medical Therapeutics

Background:

  • Leiomyosarcoma is an aggressive soft tissue sarcoma with heterogeneous characteristics.
  • Current treatments for advanced leiomyosarcoma offer limited efficacy, with short progression-free and overall survival times.
  • Understanding leiomyosarcoma's molecular drivers is crucial for developing effective therapies.

Purpose of the Study:

  • To review recent advancements in leiomyosarcoma tumor biology.
  • To explore novel therapeutic strategies based on molecular profiling.
  • To discuss the implications of these findings for clinical trials and treatment outcomes.

Main Methods:

  • Literature review of recent research on leiomyosarcoma.
  • Analysis of molecular profiling data and its therapeutic implications.
  • Evaluation of ongoing and completed clinical trials for advanced leiomyosarcoma.

Main Results:

  • Targeting DNA damage repair pathways and aberrant metabolism shows potential for advanced leiomyosarcoma.
  • Novel chemotherapy combinations are being investigated.
  • Clinical trials are essential for validating new therapeutic approaches.

Conclusions:

  • Significant progress has been made in understanding leiomyosarcoma biology and developing targeted therapies.
  • Future advancements depend on well-designed clinical trials, academic collaboration, and correlative analyses.
  • Optimizing treatment for advanced leiomyosarcoma requires integrating molecular insights into clinical practice.